Home/Arovella/Dr Deborah Barton
DD

Dr Deborah Barton

Non‑Executive Director

Arovella

Therapeutic Areas

Arovella Pipeline

DrugIndicationPhase
ALA-101CD19+ B‑cell lymphomas and leukaemiasPreclinical
ALA-105Claudin‑18.2+ gastric, gastro‑oesophageal junction, and pancreatic cancersPreclinical